The first regulatory approval of an allogeneic cell therapy goes to Atara Biotherapeutics. Other regulatory news highlights from the past week include proposed reforms of the FDA's accelerated approval process, approval of the first gene therapy for bladder cancer, and a clinical hold for a biotech developing a new class of medicines.
At the 5th annual HLTH conference in Las Vegas, healthcare executives from companies including Jean Drouin of Clarify Health, responded to questions such as what's the fastest way to assess the latest trends in the healthcare market? They also previewed their plans for 2023.
By Selin Kurnaz Thursday, December 22, 2022 5:16 PM
Engineers see everything as a system, know how to design under constraints, and recognize the need for trade-offs. Adopting an engineering mindset in oncology research can fix all the broken constituent processes like patient enrollment to systematize clinical trials.
By Jennifer Geetter, Stephen Bernstein and Lisa Mazur Thursday, December 22, 2022 2:36 PM
As we look out over the horizon to 2023, we would anticipate a rebound of investment in the digital health space but with a simultaneous and a continuing level of focused regulatory diligence as this complex landscape continues to evolve.
By Marissa Plescia Thursday, December 22, 2022 2:36 PM
Blue Cross and Blue Shield of Minnesota formed a value-based arrangement with Minnesota Oncology in 2019. Preliminary data show that it led to a reduction in the total cost of care, emergency visits and inpatient admissions.
By Hernan Bazan Thursday, December 22, 2022 1:35 PM
The future towards the safer treatment of pain will come as biopharma, and investor communities appreciate the significant opportunities in supporting scientifically rigorous and clinically validated lead assets for the safer treatment of pain.
By Katie Adams Thursday, December 22, 2022 9:16 AM
Hospitals' operational margins have shrunk dramatically this year. Now more than ever, hospitals need to ensure they're getting the most out of their investments in technology. Clear governance structures, effective communication and detailed training are among the factors hospitals need in order to get a significant return on investment for technology deployments, according to a new report.
By Gerry Miller Thursday, December 22, 2022 8:30 AM
The ability to adapt has proven paramount over the past few years and it is fundamentally reshaping healthcare IT. In 2023, that shape will increasingly form around the cloud.
By Dr. Adrienne Boissy Thursday, December 22, 2022 8:20 AM
Never has there been a time in healthcare when listening and understanding have been more critical. Issues of today are divisive, complex, and layered without easy solutions. We cannot possibly begin to fix without slowing down to listen through every channel available.
In a new eBook, executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using RWE collection to support remote patient monitoring and improve patient outcomes in neurology, cardiology and orthopedic surgery. It also explores how medtech and digital health companies can collaborate to maximize patient engagement and to navigate regulatory requirements.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments